Open Med 15(1):689696 Kojima M, Takahashi H, Kuwashiro T, Tanaka K, Mori H, Ozaki I, Kitajima Y, Matsuda Y, Ashida K, Eguchi Y, Anzai K (2020) Glucagon-like peptide-1 receptor agonist prevented the progression of hepatocellular carcinoma in a mouse model of nonalcoholic steatohepatitis
This has implications for clinical applications of the possible treatment to reduce carbohydrate or calorie intake, especially for the overweight and the obese
The study also showed that both PEPITEM and the three amino acid (tripeptide) sequence delivered a significant reduction in the severity of psoriasis, that is comparable to a steroid cream
Does this medication affect your concentration while driving
These effects help with weight loss and create new opportunities for future research